
NUVB
USDNuvation Bio Inc. Class A Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$5.150
고가
$5.190
저가
$3.920
거래량
6.20M
기업 기본 정보
시가총액
1.7B
산업
생명공학
국가
United States
거래 통계
평균 거래량
7.11M
거래소
NYQ
통화
USD
52주 범위
관련 뉴스
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8
RBC Capital analyst Leonid Timashev maintains Nuvation Bio with a Outperform and raises the price target from $7 to $8.
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Successfully started 204 patients on IBTROZI™ (taletrectinib) in the third quarter of 2025 Updated data continue to show IBTROZI's unprecedented durability in TKI-naïve, advanced ROS1-positive (ROS1+) non-small
Nuvation Bio to Participate in Upcoming Investor Conferences
Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of
관련 주식
TXN
Texas Instruments Incorporated
SSIC
Silver Spike Investment Corp.
VMEO
Vimeo Inc.
ICE
Intercontinental Exchange Inc.
NRUC
National Rural Utilities Cooperative Finance Corporation 5.500% Subordinated Notes due 2064 (Subordinated Deferrable Interest Notes)
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기